Vaccine Drug Delivery Systems

Vaccine is a material that induces an immunologically mediated resistance to a disease but not necessarily an infection. Vaccines are generally composed of killed or attenuated organisms or subunits of organisms or DNA encoding antigenic proteins of pathogens. Sub-unit vaccines though exceptionally selective and specific in reacting with antibodies often fail to show such reactions in circumstances such as shifts in epitopic identification center of antibody and are poorly immunogenic. Delivery of antigens from oil-based adjuvants such as Freunds adjuvant lead to a reduction in the number of doses of vaccine to be administered but due to toxicity concerns like inductions of granulomas at the injection site, such adjuvants are not widely used. FDA approved adjuvants for human uses are aluminium hydroxide and aluminium phosphate in the form of alum. Hence, search for safer and potent adjuvants resulted in the formulations of antigen into delivery systems that administer antigen in particulate form rather than solution form.

  • Track 1-1 Cancer vaccines
  • Track 2-2 Influenza vaccines/virus
  • Track 3-3 Novel vaccines
  • Track 4-4 Clinical trials
  • Track 5-5 Human vaccines
  • Track 6-6 HIV/AIDS vaccines
  • Track 7-7 HPV vaccines
  • Track 8-8 Therapeutic vaccination for auto immune diseases
  • Track 9-9 New vaccines
  • Track 10-10 Veterinary vaccines
  • Track 11-11 Computed Tomographic Scanning (CT Scanning)
  • Track 12-12 Magnetic Resonance Imaging

Related Conference of Pharmaceutical Sciences